⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9306489 | 0.93 | ADH1B (0.63) | — | |
| SCHEMBL543188 | 0.84 | — | — | |
| SCHEMBL22157541 | 0.83 | ADH1B (0.52) | — | |
| SCHEMBL22157537 | 0.83 | ADH1B (0.52) | — | |
| SCHEMBL22157522 | 0.79 | ADH1B (0.59) | — | |
| SCHEMBL22157525 | 0.79 | ADH1B (0.59) | — | |
| SCHEMBL22617692 | 0.78 | — | — | |
| SCHEMBL269775 | 0.78 | — | — | |
| SCHEMBL22157510 | 0.78 | — | — | |
| SCHEMBL2964896 | 0.73 | ALDH1A1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240108641-A1 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE | ANTECIP BIOVENTURES II LLC | 2024-04-04 | — | — | US | disclosed |
| US-11654152-B2 | Compositions for oral administration of zoledronic acid or related compounds for treating disease | ANTECIP BIOVENTURES II LLC (US) | 2023-05-23 | — | — | US | disclosed |
| US-10463682-B2 | Compositions for oral administration of zoledronic acid or related compounds for treating low back pain | ANTECIP BIOVENTURES II LLC (US) | 2019-11-05 | — | — | US | disclosed |
| US-20190314391-A1 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE | ANTECIP BIOVENTURES II LLC | 2019-10-17 | — | — | US | disclosed |
| US-20190290664-A9 | NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME | ANTECIP BIOVENTURES II LLC | 2019-09-26 | — | — | US | disclosed |
| US-10420782-B2 | Dosage forms for oral administration of zoledronic acid or related compounds for treating disease | ANTECIP BIOVENTURES II LLC (US) | 2019-09-24 | — | — | US | disclosed |
| US-10413560-B2 | Dosage forms for oral administration of zoledronic acid or related compounds for treating disease | ANTECIP BIOVENTURES II LLC (US) | 2019-09-17 | — | — | US | disclosed |
| US-10350227-B2 | Neridronic acid for treating complex regional pain syndrome | ANTECIP BIOVENTURES II LLC (US) | 2019-07-16 | — | — | US | disclosed |
| US-10335424-B2 | Compositions for oral administration of zoledronic acid or related compounds for treating disease | ANTECIP BIOVENTURES II LLC (US) | 2019-07-02 | — | — | US | disclosed |
| US-20190167703-A1 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE | ANTECIP BIOVENTURES II LLC | 2019-06-06 | — | — | US | disclosed |
| WO-2015184003-A1 | OSTEOCLAST INHIBITORS FOR PAIN | ANTECIP BIOVENTURES II LLP (US) | 2015-12-03 | — | — | WO | disclosed |
| US-20150157564-A1 | METHODS FOR THE SAFE ADMINISTRATION OF IMIDAZOLE OR IMIDAZOLIUM COMPOUNDS | ANTECIP BIOVENTURES II LLC | 2015-06-11 | — | — | US | disclosed |
| US-20150148312-A1 | OSTEOCLAST INHIBITORS FOR KNEE CONDITIONS | ANTECIP BIOVENTURES II LLC | 2015-05-28 | — | — | US | disclosed |
| US-20150141373-A1 | Osteoclast Inhibitors for Knee Conditions | ANTECIP BIOVENTURES II LLC | 2015-05-21 | — | — | US | disclosed |
| US-20150141374-A1 | Osteoclast Inhibitors for Knee Conditions | ANTECIP BIOVENTURES II LLC | 2015-05-21 | — | — | US | disclosed |
| US-20150133403-A1 | Osteoclast Inhibitors for Knee Conditions | ANTECIP BIOVENTURES II LLP | 2015-05-14 | — | — | US | disclosed |
| US-20040097728-A1 | Method for producing anellated tetrahydro-{1h}-triazoles | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-20 | — | — | US | disclosed |
| US-6639070-B1 | 4-substituted 1,3,4-oxadiazines; herbicides | BASF AKTIENGESELLSCHAFT (DE) | 2003-10-28 | — | — | US | disclosed |
| EP-1187819-B1 | N-SUBSTITUTED PERHYDRO DIAZINE | BASF AG (DE) | 2003-07-23 | — | — | EP | disclosed |
| US-6528455-B1 | Post or preemergence herbicides such as 3-(4-chloro-2-fluoro -5-(1-methoxycarbonyl-1-vinyloxy)phenyl)-1-methyl-6-trifluoro methyl-2,4-pyrimidinedione | BASF AKTIENGESELLSCHAFT (DE) | 2003-03-04 | — | — | US | disclosed |